Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

TYRUKO natalizumab 300 mg/15 mL concentrate for infusion vial (425612)

ARTG ID

425612

ARTG Name

TYRUKO natalizumab 300 mg/15 mL concentrate for infusion vial

Sponsor

Sandoz Pty Ltd

ARTG Date

April 4, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Sandoz Pty Ltd.

Active Ingredients

Ingredient Name

Natalizumab

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy